These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29541941)

  • 1. Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine.
    Luo F; Liao FL; Wang H; Tang HB; Yang ZQ; Hou W
    Virol Sin; 2018 Apr; 33(2):201-204. PubMed ID: 29541941
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
    Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
    J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
    Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine.
    Qin E; Shi H; Tang L; Wang C; Chang G; Ding Z; Zhao K; Wang J; Chen Z; Yu M; Si B; Liu J; Wu D; Cheng X; Yang B; Peng W; Meng Q; Liu B; Han W; Yin X; Duan H; Zhan D; Tian L; Li S; Wu J; Tan G; Li Y; Li Y; Liu Y; Liu H; Lv F; Zhang Y; Kong X; Fan B; Jiang T; Xu S; Wang X; Li C; Wu X; Deng Y; Zhao M; Zhu Q
    Vaccine; 2006 Feb; 24(7):1028-34. PubMed ID: 16388880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates.
    Wang Q; Zhang L; Kuwahara K; Li L; Liu Z; Li T; Zhu H; Liu J; Xu Y; Xie J; Morioka H; Sakaguchi N; Qin C; Liu G
    ACS Infect Dis; 2016 May; 2(5):361-76. PubMed ID: 27627203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys.
    Zhou J; Wang W; Zhong Q; Hou W; Yang Z; Xiao SY; Zhu R; Tang Z; Wang Y; Xian Q; Tang H; Wen L
    Vaccine; 2005 May; 23(24):3202-9. PubMed ID: 15837221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
    Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
    J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
    See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
    J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses.
    Tsunetsugu-Yokota Y; Ato M; Takahashi Y; Hashimoto S; Kaji T; Kuraoka M; Yamamoto K; Mitsuki YY; Yamamoto T; Oshima M; Ohnishi K; Takemori T
    Jpn J Infect Dis; 2007 May; 60(2-3):106-12. PubMed ID: 17515642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.
    Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM
    Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.
    Lin JT; Zhang JS; Su N; Xu JG; Wang N; Chen JT; Chen X; Liu YX; Gao H; Jia YP; Liu Y; Sun RH; Wang X; Yu DZ; Hai R; Gao Q; Ning Y; Wang HX; Li MC; Kan B; Dong GM; An Q; Wang YQ; Han J; Qin C; Yin WD; Dongs XP
    Antivir Ther; 2007; 12(7):1107-13. PubMed ID: 18018769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
    Roberts A; Lamirande EW; Vogel L; Baras B; Goossens G; Knott I; Chen J; Ward JM; Vassilev V; Subbarao K
    Viral Immunol; 2010 Oct; 23(5):509-19. PubMed ID: 20883165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine.
    Gai W; Zou W; Lei L; Luo J; Tu H; Zhang Y; Wang K; Tien P; Yan H
    Viral Immunol; 2008 Mar; 21(1):27-37. PubMed ID: 18355120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models and vaccines for SARS-CoV infection.
    Roberts A; Lamirande EW; Vogel L; Jackson JP; Paddock CD; Guarner J; Zaki SR; Sheahan T; Baric R; Subbarao K
    Virus Res; 2008 Apr; 133(1):20-32. PubMed ID: 17499378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.
    Qu D; Zheng B; Yao X; Guan Y; Yuan ZH; Zhong NS; Lu LW; Xie JP; Wen YM
    Vaccine; 2005 Jan; 23(7):924-31. PubMed ID: 15603894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
    Tseng CT; Sbrana E; Iwata-Yoshikawa N; Newman PC; Garron T; Atmar RL; Peters CJ; Couch RB
    PLoS One; 2012; 7(4):e35421. PubMed ID: 22536382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain.
    Zhang CH; Guo ZM; Zheng HY; Lu JH; Wang YF; Yan XG; Zhao Y; DU XW; Zhang X; Fang L; Ling WH; Qi SY; Yu XB; Zhong NS
    Chin Med J (Engl); 2004 Nov; 117(11):1625-9. PubMed ID: 15569476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.